InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,454.80
(
0.20%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.42
(
0.35%
)
Bitcoin
0.00
(
0.00%
)
Post# of 251721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mouton29 post# 219736

Thursday, 06/21/2018 6:34:47 PM

Thursday, June 21, 2018 6:34:47 PM

Post# of 251721
Re: RVNC phase-3 CD program

...the new news is only that the phase III trial has started dosing.

It's also helpful to have confirmation in today's PR that only one phase-3 efficacy trial in CD will be needed. Apparently, the FDA/EMA recognize that a longer-acting toxin for CD patients is an unmet medical need.

RVNC PR:
https://investors.revance.com/news-releases/news-release-details/revance-doses-first-patient-aspen-phase-3-clinical-program-rt002

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up